• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Pressure Problem (3012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/16/2022
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: requested, not provided.Age: requested, not provided.Ethnicity: requested, not provided.Race: requested, not provided.Implanted date: device was not implanted.Explanted date: device was not explanted.Initial reporter name: unknown.Phone number: unknown.Health professional: unknown.Occupation: unknown.Pma/510(k) #: k130520.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.The manufacturing record and the shipping inspection record of the actual product found no anomaly.No other similar report was found with the product of the involved product code/lot number.Terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Event Description
The user facility reported high pressure with the oxygenator involved.High delta p during the procedure.The oxygenator was not exchanged due to the progress of the procedure.The procedure could be finished with the complained oxygenator.The event occurred intra-operative.There was no patient injury/medical or surgical intervention required.There was no harm to the patient.
 
Manufacturer Narrative
H6: investigation conclusions: code 4310 is based upon the investigation of the provided information; code 67 is based upon investigation of the returned sample.This report is being submitted as follow up no.1 to provide the device return date in section d9, update section h3, and to provide the completed investigation results.Visual inspection of the actual sample upon receipt found no anomaly such as a breakage was found.After rinsing and drying the actual sample, the oxygenator was installed into a circuit consisting of tubes, and bovine blood (hct: 35%, temp.: 37°c) was circulated with a flow rate of 8.0 l/min.Then, the pressure drop was measured.It was confirmed to meet the factory's specifications and no obstruction was found.After circulation of bovine blood, saline solution was flowed in the blood channel.No blood clot that led to the obstruction was formed.The contents of pump record were confirmed.However, it was not possible to read the cause of the increase in pressure drop.Review of the manufacturing record and the shipping inspection record of the actual sample confirmed that there was not any anomaly in them.A search of the complaint file found no other similar report of the product with the involved product code/lot number combination.Based on the investigation result, no anomaly was found in the actual sample after rinsing.As a cause of occurrence, it was likely that blood-derived obstruction occurred for some reason.However, since no anomaly was found in the performance test of actual sample, it was not possible to clarify the cause of this complaint from the investigation result.Relevant ifu reference: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.(warnings)" "adequate heparinization of the blood is required to prevent it from clotting in the system.(warnings)".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
6402040886
MDR Report Key15987052
MDR Text Key308283843
Report Number9681834-2022-00252
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701060
UDI-Public04987350701060
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCX*FX25E
Device Lot Number220517
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received01/16/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age56 YR
Patient SexMale
Patient Weight153 KG
-
-